Advertisement

Topics

MMRF’s MyDRUG Platform Trial Aims For Efficiency In Testing Treatments For Myeloma Mutations

14:51 EDT 9 May 2019 | SCRIP

The adaptive trial design will help test smaller subpopulations and could lead to more effective and cost-efficient treatment strategies.

      

Related Stories

 

Original Article: MMRF’s MyDRUG Platform Trial Aims For Efficiency In Testing Treatments For Myeloma Mutations

NEXT ARTICLE

More From BioPortfolio on "MMRF’s MyDRUG Platform Trial Aims For Efficiency In Testing Treatments For Myeloma Mutations"

Advertisement
Quick Search
Advertisement
Advertisement